SCHEMBL14417016

SCHEMBL14417016

CC1O[C@@H](OCC2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)C(O)[C@H](O)[C@@H]2O[C@@H]2OC(CO)[C@@H](O)[C@@H](O)C2O)C(O)[C@@H](O)[C@H]1O

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HB P07237 6/20 0.88
▸ L3MBTL1 Q9Y468 3/20 0.88
▸ ALPL P05186 2/20 0.88
▸ ALPI P09923 2/20 0.88
▸ ALPG P10696 1/20 0.88
▸ KDM4E B2RXH2 7/20 0.83
▸ GAA P10253 6/20 0.83
▸ MAPT P10636 5/20 0.83
▸ POLB P06746 5/20 0.83
▸ EPHX2 P34913 3/20 0.83
▸ XDH P47989 3/20 0.83
▸ HES1 Q14469 2/20 0.83
▸ FANCF Q9NPI8 2/20 0.83
▸ KDM1A O60341 2/20 0.83
▸ HMGB1 P09429 2/20 0.83
▸ ADRA2C P18825 2/20 0.83
▸ MAOA P21397 2/20 0.83
▸ MAPK1 P28482 2/20 0.83
▸ PRSS1 P07477 1/20 0.83
▸ PRSS2 P07478 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29366789 1.00 P4HB (0.88) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL1566365 1.00 P4HB (0.88) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL14420999 1.00 P4HB (0.88) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL20801883 0.96 KDM4E (0.83) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL20802110 0.96 KDM4E (0.83) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL20801873 0.96 KDM4E (0.83) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL30430130 0.95 KDM4E (0.82) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL30637460 0.94 KDM4E (0.83) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL30096465 0.93 KDM4E (0.88) P4HBL3MBTL1ALPLALPIALPG
SCHEMBL31720515 0.93 P4HB (0.90) P4HBL3MBTL1ALPLALPIALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070207103-A1 Lipophilic personal care composition THE PROCTER & GAMBLE COMPANY 2007-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070207103-A1 Lipophilic personal care composition CUTA, PLIN3, PLIN5 P4HB 1840/4885L3MBTL1 1799/4885ALPL 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback